Clinical and Experimental Medicine - Editor-in-Chief Highlights: May 2021
Find Professor Dammacco's Editor-in-Chief Highlights from our May 2021 issue (Vol 21, Issue 2) below. You can access the complete issue here (this opens in a new tab).
COVID-19: time to flatten the infodemic curve (this opens in a new tab)
Anastasios Tentolouris et al.
Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment (this opens in a new tab)
Samaneh Arab, Akram Alizadeh & Samira Asgharzade.
Overexpression of miR-1225 promotes the progression of breast cancer, resulting in poor prognosis (this opens in a new tab)
Peng Shi et al.
The association of transforming growth factor beta 1 gene polymorphisms with arthritis: a systematic review and meta-analysis (this opens in a new tab)
Suling Liu, Jiaxiao Li & Yang Cui.
IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma (this opens in a new tab)
Tetsuhiro Kasamatsu et al.